ABIVAX Société Anonyme (EPA: ABVX) Stock Analysis & Fundamentals

ABVXABIVAX Société Anonyme

EPA · FR · Healthcare · Biotechnology · abivax.com

101.40EUR+1.30%Mkt Cap: 9.65B $P/E: —Today

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.…

Headline	Source	Time
Older
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26	TradingView	Aug 12
Abivax: Objectif de Cours et Consensus des Analystes \| ABVX \| FR0012333284	Zonebourse	Jul 31
AbbVie Q2 Earnings Call Highlights AbbVie (NYSE:ABBV) reported second-quarter 2026 results that exceeded its expectations, supported by double-digit growth in its immunology and neuroscience businesses, and raised its full-year revenue outlook by $300 million. Chairman and Chief Executive Officer Rob Michael said adjusted earnings p	MarketBeat	Jul 31
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In? ABIVAX Société Anonyme (ENXTPA:ABVX) has drawn fresh attention after expanding its commercial leadership team by adding four senior executives across marketing, patient services, sales and commercial operations, and market access for its lead candidate, obefazimod. See our latest analysis for ABIVAX Société Anonyme. Those commercial hires and the recent R&D collaboration with Valerio Therapeutics come after a period where ABIVAX Société Anonyme’s 1 month share price return of 33.49% contrasts...	Simply Wall St.	Jul 26
Abivax (ENXTPA:ABVX) Adds Commercial Leaders And Signs Valerio R And D Deal Abivax has expanded its Commercial Leadership Team to prepare for potential U.S. commercialization of obefazimod. The company has agreed a binding term sheet for an exclusive worldwide R&D collaboration with Valerio Therapeutics to develop next generation immune mediated inflammatory disease therapies. The moves combine commercial build out with access to RNA technology platforms and new therapeutic candidates. ABIVAX Société Anonyme (ENXTPA:ABVX) is stepping up its U.S. ambitions as it...	Simply Wall St.	Jul 25
ABIVAX Société Anonyme : Morgan Stanley toujours à l'achat	Zonebourse	Jul 24
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?	Zacks	Jul 10
Abivax CEO says $920M raise funds U.S. drug launch without Big Pharma	Quartz	Jul 10
3 Soaring Stocks That May Have More Upside Ahead	Motley Fool	Jul 8
Abivax: Wall Street Catches Up to the Data	MarketBeat	Jul 7
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says	MMT Newswires	Jul 6
Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now?	IInsider Monkey	Jul 4
ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds	Stocktwits	Jul 2
Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet	The Wall Street Journal	Jul 2
Abivax jumps as fully exercised option lifts share-sale haul to $920 million	Investing.com	Jul 2
Abivax bondit après une option exercée portant la levée à 920 millions $	Yahoo Finance France	Jul 2
ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress	Simply Wall St.	Jul 2
Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease	Investing.com	Jul 1
Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures	Stocktwits	Jul 1
Here Are Wednesday’s Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More	24/7 Wall St.	Jul 1
Abivax shares surge as worries subside over immune drug’s cancer risk	BioPharma Dive	Jul 1
Abivax a fixé le prix de l'offre de ses ADS, le titre va reprendre sa cotation	Zonebourse	Jul 1
From Cancer Scare to Comeback, Abivax Shares Erase a Month of Losses in a Day	BeInCrypto	Jul 1
ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns	Stocktwits	Jul 1
Stocks to Watch: Strategy, Super Micro, Nike	The Wall Street Journal	Jun 30
Abivax Stock Soars 36% After Trial Update Eases Cancer Concerns	GuruFocus.com	Jun 30
Abivax shares jump as updated trial data eases safety concerns	Proactive	Jun 30
Abivax stock surges on obefazimod safety data, cancer concerns	Quartz	Jun 30
Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod	Euronews	Jun 30
ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data	Stocktwits	Jun 30
🔎 Under the Radar: Abivax Shares Rise on Expanded Safety Data for Ulcerative Colitis Drug	The Wall Street Journal	Jun 30
cAMPfield lands $180M to build gut disease drug	BioPharma Dive	Jun 18
Guggenheim désigne sa meilleure valeur biotechnologique	Investing.com France	Jun 18
Abivax (ABVX) Reports Positive Phase 3 Maintenance Trial Results for Obefazimod in Ulcerative Colitis	IInsider Monkey	Jun 17
Abivax (ABVX) Reports Q1 2026 Financial Results with Cash Runway Extending Through 2027	IInsider Monkey	Jun 17
Abivax, Ipsen et Soitec rejoignent le CAC Next 20	Zonebourse	Jun 12
European Value Stocks Trading Below Estimated Intrinsic Values June 2026	Simply Wall St.	Jun 10
High Growth Tech Stocks To Watch In The Global Market	Simply Wall St.	Jun 5
Abivax (ABVX) Jumps 16% on Bargain-Hunting	IInsider Monkey	Jun 5
European shares rise as oil slips, investors watch Middle East	Reuters	Jun 4
Abivax (ABVX) Skyrockets 24% After Steep Fall	IInsider Monkey	Jun 4
This Stock Is Up 1,000% Over the Past Year. Is There More Upside Ahead?	Motley Fool	Jun 3
Assessing Abivax (ENXTPA:ABVX) Valuation After Phase 3 Obefazimod Data And Safety Concerns	Simply Wall St.	Jun 3
Abivax SA Sponsored ADR (ABVX) Loses 41.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner	Zacks	Jun 3
ABVX Stock Clocks Worst Day Ever On Malignancy Signal For Drug: ‘Pharma Bro’ Says ‘GLPs Are Doing Fine’ After Similar Fears	Stocktwits	Jun 3
Sector Update: Healthcare Stocks Softer Late Afternoon	MMT Newswires	Jun 2
Abivax Drops 32% As Cancer Cases Cloud Key Drug Trial	GuruFocus.com	Jun 2
Abivax Faces Increasing Risk of Black Box Warning for Obefazimod, Wedbush Says	MMT Newswires	Jun 2
Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data	Moby	Jun 2
Abivax stock plunges on cancer signal in ulcerative colitis trial	Quartz	Jun 2

Industry Peers